MENU
JSMD
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

JSMD stock forecast, quote, news & analysis

The investment seeks to provide long-term growth of capital... Show more

Category: #Small Growth
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for JSMD with price predictions
Nov 11, 2026

JSMD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for JSMD turned positive on November 11, 2026. Looking at past instances where JSMD's MACD turned positive, the stock continued to rise in 48 of 52 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2026. You may want to consider a long position or call options on JSMD as a result. In 75 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.

JSMD moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where JSMD advanced for three days, in 256 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

JSMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for JSMD moved below the 200-day moving average on November 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JSMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for JSMD entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Guardant Health (NASDAQ:GH), Exelixis (NASDAQ:EXEL), Lattice Semiconductor Corp (NASDAQ:LSCC), RH (NYSE:RH), BioCryst Pharmaceuticals (NASDAQ:BCRX), PagerDuty (NYSE:PD).

Industry description

The investment seeks to provide long-term growth of capital. The fund will, under normal circumstances, invest at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities of small- and mid-sized capitalization (“small/mid cap”) companies selected for their growth potential. For purposes of the 80% policy, the fund's managers consider small/mid cap companies to be those whose market capitalization falls within the 12-month range of the Russell 2500TM Growth Index.

Market Cap

The average market capitalization across the Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) ETF is 5.16B. The market cap for tickers in the group ranges from 332.84M to 23.94B. ATI holds the highest valuation in this group at 23.94B. The lowest valued company is VRRM at 332.84M.

High and low price notable news

The average weekly price growth across all stocks in the Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) ETF was 0%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was -2%. XERS experienced the highest price growth at 58%, while VCYT experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) ETF was -35%. For the same stocks of the ETF, the average monthly volume growth was 23% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 50
Price Growth Rating: 51
SMR Rating: 53
Profit Risk Rating: 66
Seasonality Score: 11 (-100 ... +100)